Caribou Biosciences Ownership 2024 | Who Owns Caribou Biosciences Now?
Institutional Ownership
11.42%
Insider Ownership
10.05%
Retail Ownership
78.53%
Institutional Holders
53.00
Caribou Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 7.78% | 0.00% | 6,947,820 | -57,242 | -0.82% | 11,394,426 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.09% | 0.00% | 4,544,706 | 433,911 | 10.56% | 7,453,318 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 4.66% | 0.00% | 4,162,347 | 3,045,578 | 272.71% | 6,826,249 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 4.57% | 0.33% | 4,083,372 | -2,399,898 | -37.02% | 6,696,730 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.94% | 0.00% | 2,623,283 | 536,162 | 25.69% | 4,302,402 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.62% | 0.01% | 2,343,540 | -1,241,478 | -34.63% | 3,843,406 | Jun 30, 2024 |
| ELMWOOD WEALTH MANAGEMENT, INC. | 2.61% | 1.71% | 2,334,740 | -29,500 | -1.25% | 3,828,974 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.13% | 0.00% | 1,905,661 | 63,478 | 3.45% | 3,125,716 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.84% | 0.21% | 1,646,702 | 578,175 | 54.11% | 2,700,591 | Jun 30, 2024 |
| STATE STREET CORP | 1.81% | 0.00% | 1,615,579 | -4,731,742 | -74.55% | 2,649,550,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.66% | 0.00% | 1,482,900 | 1,482,900 | 100.00% | 2,431,956 | Jun 30, 2024 |
| FMR LLC | 1.65% | 0.00% | 1,471,887 | 26,725 | 1.85% | 2,413,894 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.33% | 0.00% | 1,188,764 | 585,862 | 97.17% | 1,949,573 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.25% | 0.00% | 1,119,185 | 889,438 | 387.14% | 1,835,463 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.00% | 0.01% | 891,856 | -951,058 | -51.61% | 1,462,643 | Jun 30, 2024 |
| FIL LTD | 0.96% | 0.00% | 860,666 | - | - | 1,411,492 | Jun 30, 2024 |
| ROKOS CAPITAL MANAGEMENT LLP | 0.94% | 0.01% | 840,630 | - | - | 1,374,430 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.81% | 0.00% | 720,522 | 599,033 | 493.08% | 1,181,656 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.80% | 0.00% | 710,129 | -24,136 | -3.29% | 1,164,612,000 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 0.73% | 0.02% | 652,542 | - | - | 1,070,169 | Jun 30, 2024 |
Caribou Biosciences's largest institutional shareholder is BLACKROCK INC., holding 7.78% of the company's total share outstanding, currently valued at $11.39M. The top 10 institutional shareholders own together 36.07% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| 72 INVESTMENT HOLDINGS, LLC | 0.53% | 1.95% | 474,067 | - | - | 777,470 | Jun 30, 2024 |
| ELMWOOD WEALTH MANAGEMENT, INC. | 2.61% | 1.71% | 2,334,740 | -29,500 | -1.25% | 3,828,974 | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 4.57% | 0.33% | 4,083,372 | -2,399,898 | -37.02% | 6,696,730 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.84% | 0.21% | 1,646,702 | 578,175 | 54.11% | 2,700,591 | Jun 30, 2024 |
| BRUCE & CO., INC. | 0.34% | 0.16% | 300,000 | 100,000 | 50.00% | 492,000 | Jun 30, 2024 |
| GREEN ALPHA ADVISORS, LLC | 0.09% | 0.10% | 77,371 | -6,150 | -7.36% | 126,888 | Jun 30, 2024 |
| MILESTONE ASSET MANAGEMENT, LLC | 0.16% | 0.06% | 142,310 | 142,310 | 100.00% | 233,388 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.23% | 0.03% | 208,162 | 208,162 | 100.00% | 341,386 | Jun 30, 2024 |
| NELSON CAPITAL MANAGEMENT, LLC | 0.10% | 0.02% | 85,020 | - | - | 139,433 | Jun 30, 2024 |
| RESONANT CAPITAL ADVISORS, LLC | 0.21% | 0.02% | 184,198 | - | - | 302,085 | Jun 30, 2024 |
| BALBOA WEALTH PARTNERS | 0.05% | 0.02% | 47,876 | 47,876 | 100.00% | 78,517 | Jun 30, 2024 |
| MAVERICK CAPITAL LTD | 0.73% | 0.02% | 652,542 | - | - | 1,070,169 | Jun 30, 2024 |
| KRAEMATON INVESTMENT ADVISORS, INC | 0.01% | 0.02% | 10,000 | 10,000 | 100.00% | 16,400 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.04% | 0.01% | 31,831 | 31,831 | 100.00% | 52,203 | Jun 30, 2024 |
| THRIVE WEALTH MANAGEMENT, LLC | 0.04% | 0.01% | 32,000 | - | - | 52,480 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.62% | 0.01% | 2,343,540 | -1,241,478 | -34.63% | 3,843,406 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.04% | 0.01% | 35,305 | -449 | -1.26% | 57,900 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.00% | 0.01% | 891,856 | -951,058 | -51.61% | 1,462,643 | Jun 30, 2024 |
| ROKOS CAPITAL MANAGEMENT LLP | 0.94% | 0.01% | 840,630 | - | - | 1,374,430 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.03% | 0.01% | 24,428 | 24,428 | 100.00% | 40,062 | Jun 30, 2024 |
The largest Caribou Biosciences shareholder by % of total assets is 72 INVESTMENT HOLDINGS, LLC. The company owns 474.07K shares of Caribou Biosciences (CRBU), representing 1.95% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 4.66% | 0.00% | 4,162,347 | 3,045,578 | 272.71% | 6,826,249 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 1.66% | 0.00% | 1,482,900 | 1,482,900 | 100.00% | 2,431,956 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 1.25% | 0.00% | 1,119,185 | 889,438 | 387.14% | 1,835,463 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.81% | 0.00% | 720,522 | 599,033 | 493.08% | 1,181,656 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.33% | 0.00% | 1,188,764 | 585,862 | 97.17% | 1,949,573 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.84% | 0.21% | 1,646,702 | 578,175 | 54.11% | 2,700,591 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 2.94% | 0.00% | 2,623,283 | 536,162 | 25.69% | 4,302,402 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.09% | 0.00% | 4,544,706 | 433,911 | 10.56% | 7,453,318 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.25% | 0.00% | 220,017 | 220,017 | 100.00% | 360,828 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.23% | 0.03% | 208,162 | 208,162 | 100.00% | 341,386 | Jun 30, 2024 |
| MORGAN STANLEY | 0.69% | 0.00% | 618,487 | 203,990 | 49.21% | 1,014,318 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.21% | 0.00% | 191,562 | 191,562 | 100.00% | 314,162 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.18% | 0.00% | 162,800 | 162,800 | 100.00% | 266,992 | Jun 30, 2024 |
| MILESTONE ASSET MANAGEMENT, LLC | 0.16% | 0.06% | 142,310 | 142,310 | 100.00% | 233,388 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.12% | 0.00% | 106,985 | 106,985 | 100.00% | 175,000 | Jun 30, 2024 |
| BRUCE & CO., INC. | 0.34% | 0.16% | 300,000 | 100,000 | 50.00% | 492,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.19% | 0.00% | 171,560 | 86,930 | 102.72% | 281,358 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.59% | 0.00% | 523,250 | 81,444 | 18.43% | 858,130 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.09% | 0.00% | 77,121 | 66,867 | 652.11% | 126,479 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.09% | 0.00% | 80,867 | 66,838 | 476.43% | 128,983 | Jun 30, 2024 |
As of Jun 30 2024, Caribou Biosciences's largest institutional buyer is BANK OF AMERICA CORP /DE/. The company purchased 3.05M stocks of CRBU, valued at $6.83M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -5,785,352 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 1.81% | 0.00% | 1,615,579 | -4,731,742 | -74.55% | 2,649,550,000 | Jun 30, 2024 |
| ALKEON CAPITAL MANAGEMENT LLC | - | - | - | -2,743,505 | -100.00% | - | Jun 30, 2024 |
| PFM HEALTH SCIENCES, LP | 4.57% | 0.33% | 4,083,372 | -2,399,898 | -37.02% | 6,696,730 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | - | - | - | -2,172,620 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 2.62% | 0.01% | 2,343,540 | -1,241,478 | -34.63% | 3,843,406 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 1.00% | 0.01% | 891,856 | -951,058 | -51.61% | 1,462,643 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | - | - | - | -541,449 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.70% | 0.01% | 625,063 | -520,000 | -45.41% | 1,025,055 | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | - | - | - | -344,495 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.12% | - | 106,536 | -301,739 | -73.91% | 174,719 | Jun 30, 2024 |
| WESTWOOD HOLDINGS GROUP INC | - | - | - | -251,467 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | - | 2,696 | -227,496 | -98.83% | 4,529 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.70% | 0.00% | 621,205 | -203,452 | -24.67% | 1,018,776 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.18% | 0.00% | 164,948 | -203,309 | -55.21% | 270,515 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -158,612 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -156,238 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -153,933 | -100.00% | - | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -125,000 | -100.00% | - | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | 0.16% | 0.00% | 142,912 | -116,016 | -44.81% | 234,376 | Jun 30, 2024 |
As of Jun 30 2024, Caribou Biosciences's biggest institutional seller is AVIDITY PARTNERS MANAGEMENT LP. The company sold -5.79M shares of CRBU, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.25% | 0.00% | 220,017 | 220,017 | 100.00% | 360,828 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.23% | 0.03% | 208,162 | 208,162 | 100.00% | 341,386 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.21% | 0.00% | 191,562 | 191,562 | 100.00% | 314,162 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.18% | 0.00% | 162,800 | 162,800 | 100.00% | 266,992 | Jun 30, 2024 |
| MILESTONE ASSET MANAGEMENT, LLC | 0.16% | 0.06% | 142,310 | 142,310 | 100.00% | 233,388 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.12% | 0.00% | 106,985 | 106,985 | 100.00% | 175,000 | Jun 30, 2024 |
| BALBOA WEALTH PARTNERS | 0.05% | 0.02% | 47,876 | 47,876 | 100.00% | 78,517 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 44,261 | 44,261 | 100.00% | 72,588 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.04% | - | 33,148 | 33,148 | 100.00% | 54,363 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.04% | 0.01% | 31,831 | 31,831 | 100.00% | 52,203 | Jun 30, 2024 |
| EQIS CAPITAL MANAGEMENT, INC. | 0.03% | 0.00% | 25,807 | 25,807 | 100.00% | 42,324 | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | 0.03% | 0.01% | 24,428 | 24,428 | 100.00% | 40,062 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.02% | 0.00% | 19,562 | 19,562 | 100.00% | 32,082 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.02% | - | 18,341 | 18,341 | 100.00% | 30,079 | Jun 30, 2024 |
| SIMPLICITY WEALTH,LLC | 0.01% | 0.00% | 12,795 | 12,795 | 100.00% | 20,984 | Jun 30, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | 0.01% | 0.00% | 12,795 | 12,795 | 100.00% | 20,984 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.01% | - | 12,195 | 12,195 | 100.00% | 20,000 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.01% | - | 11,406 | 11,406 | 100.00% | 18,705 | Jun 30, 2024 |
| KRAEMATON INVESTMENT ADVISORS, INC | 0.01% | 0.02% | 10,000 | 10,000 | 100.00% | 16,400 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 3,169 | 3,169 | 100.00% | 5,197,000 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,846 | 1,846 | 100.00% | 3,027 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 851 | 851 | 100.00% | 1,396 | Jun 30, 2024 |
| COMERICA BANK | 0.00% | - | 127 | 127 | 100.00% | 208 | Jun 30, 2024 |
Caribou Biosciences's largest new institutional shareholder by number of shares is QUBE RESEARCH & TECHNOLOGIES LTD, purchased 220.02K shares, valued at $360.83K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | - | - | - | -5,785,352 | -100.00% | - | Jun 30, 2024 |
| ALKEON CAPITAL MANAGEMENT LLC | - | - | - | -2,743,505 | -100.00% | - | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | - | - | - | -2,172,620 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | - | - | - | -541,449 | -100.00% | - | Jun 30, 2024 |
| READYSTATE ASSET MANAGEMENT LP | - | - | - | -344,495 | -100.00% | - | Jun 30, 2024 |
| WESTWOOD HOLDINGS GROUP INC | - | - | - | -251,467 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -158,612 | -100.00% | - | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -156,238 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -153,933 | -100.00% | - | Jun 30, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | - | - | - | -125,000 | -100.00% | - | Jun 30, 2024 |
| PROFUND ADVISORS LLC | - | - | - | -83,787 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -82,100 | -100.00% | - | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | - | - | - | -73,192 | -100.00% | - | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | - | - | - | -63,600 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -57,657 | -100.00% | - | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | - | - | - | -50,962 | -100.00% | - | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | - | - | - | -42,653 | -100.00% | - | Jun 30, 2024 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | - | - | - | -42,266 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -40,347 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -36,555 | -100.00% | - | Jun 30, 2024 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | - | - | - | -30,703 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -29,583 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -29,284 | -100.00% | - | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | - | - | - | -26,592 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -25,586 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | - | - | - | -23,897 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -22,062 | -100.00% | - | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | - | - | - | -14,044 | -100.00% | - | Jun 30, 2024 |
| AXQ CAPITAL, LP | - | - | - | -13,750 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -13,654 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -11,954 | -100.00% | - | Jun 30, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -4,652 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -4,221 | -100.00% | - | Jun 30, 2024 |
| PACER ADVISORS, INC. | - | - | - | -2,516 | -100.00% | - | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | - | - | - | -703 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -262 | -100.00% | - | Jun 30, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -176 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -17 | -100.00% | - | Jun 30, 2024 |
Caribou Biosciences's largest sold out institutional shareholder by shares sold is AVIDITY PARTNERS MANAGEMENT LP, sold -5.79M shares, valued at -, as of undefined.
Caribou Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Kelly Strategic ETF Trust | 0.80% | 21,784 | - | - | Feb 29, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.53% | 258,928 | 5,826 | 2.30% | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.45% | 385,660 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.38% | 181,487 | - | - | Mar 31, 2024 |
| Ark ETF Trust | 0.18% | 1,484,672 | - | - | Jan 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.13% | 392,210 | -57,837 | -12.85% | Mar 31, 2024 |
| RMB INVESTORS TRUST | 0.12% | 64,081 | 1,721 | 2.76% | Dec 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.11% | 237,975 | - | - | Feb 29, 2024 |
| SHELTON FUNDS | 0.10% | 172,800 | - | - | Feb 29, 2024 |
| BRUCE FUND INC | 0.10% | 200,000 | - | - | Dec 31, 2023 |
| ACAP Strategic Fund | 0.09% | 1,348,787 | -167,362 | -11.04% | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.09% | 45,084 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.03% | 27,800 | 4,633 | 20.00% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 135,148 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 12,613 | - | - | Mar 31, 2024 |
| Listed Funds Trust | 0.01% | 47,053 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 394,398 | 181,565 | 85.31% | Jan 31, 2024 |
| ETFis Series Trust I | 0.01% | 13,300 | -8,058 | -37.73% | Jan 31, 2024 |
| Investment Managers Series Trust II | 0.01% | 107,594 | -1,303 | -1.20% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,566,499 | -1,083,699 | -23.30% | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 59,360 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,471 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 783,859 | 86,945 | 12.48% | Feb 29, 2024 |
| Destra Investment Trust | 0.00% | 5,019 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,487 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 28,124 | 6,035 | 27.32% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 365,999 | -32,438 | -8.14% | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 57,980 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 47,861 | -4,066 | -7.83% | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 433,947 | - | - | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 25,468 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 28,148 | 4,510 | 19.08% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 513,423 | 377,412 | 277.49% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,201,349 | 631,300 | 110.74% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 12,418 | -1,021 | -7.60% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 27,052 | -5,632 | -17.23% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 4,024 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 86,415 | 34,943 | 67.89% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 434,966 | 50,910 | 13.26% | Feb 29, 2024 |
| Managed Portfolio Series | 0.00% | 16,522 | -2,143 | -11.48% | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 50,873 | 48 | 0.09% | Jan 31, 2024 |
| TARGET PORTFOLIO TRUST | 0.00% | 11,400 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 73,675 | -11,009 | -13.00% | Mar 28, 2024 |
| Global X Funds | 0.00% | 21,517 | -114,115 | -84.14% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 29,300 | 2,400 | 8.92% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 4,703 | 576 | 13.96% | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 36,017 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 983 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 5,095 | 284 | 5.90% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 3,699,837 | -140,565 | -3.66% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 228,516 | -1,553 | -0.68% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 359,145 | 65,768 | 22.42% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 715 | 196 | 37.76% | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 12,144 | 3,505 | 40.57% | Mar 31, 2024 |
| SPDR SERIES TRUST | 0.00% | 4,667,837 | 1,112,717 | 31.30% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 31,418 | 2,635 | 9.15% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 3,000 | 1,000 | 50.00% | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 12,763 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 367 | 110 | 42.80% | Dec 31, 2023 |
| MAINSTAY FUNDS TRUST | 0.00% | 17,446 | 17,446 | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 246,620 | 10,367 | 4.39% | Jan 31, 2024 |
| LoCorr Investment Trust | 0.00% | 1,900 | - | - | Mar 31, 2024 |
| Two Roads Shared Trust | 0.00% | 2,853 | 2,853 | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 18,603 | 3,325 | 21.76% | Feb 29, 2024 |
| MAINSTAY VP FUNDS TRUST | 0.00% | 8,802 | 8,802 | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 8,221 | -240 | -2.84% | Jan 31, 2024 |
| ALLSPRING FUNDS TRUST | 0.00% | 24,782 | 3,861 | 18.46% | Mar 31, 2024 |
| Pacer Funds Trust | 0.00% | 2,083 | 2,083 | - | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 269 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 49 | 15 | 44.12% | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 103,164 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 9,698 | 1,356 | 16.26% | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,851 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,156 | - | - | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 9,423 | -141 | -1.47% | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 25,882 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 9,913 | 778 | 8.52% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,390 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 17,393 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 1,260 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 60,770 | -1,950 | -3.11% | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 31,154 | -858 | -2.68% | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 6,211 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 48,631 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 435 | - | - | Mar 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 7,303 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 661 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 33,655 | -1,228 | -3.52% | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 2,600 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 2,355 | 795 | 50.96% | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 34,118 | - | - | Mar 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 1,375 | - | - | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 2,195 | - | - | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,970 | - | - | Dec 31, 2023 |
| MUTUAL FUND SERIES TRUST | 0.00% | 16,000 | - | - | Mar 31, 2024 |
| WisdomTree Trust | 0.00% | 5,882 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 9,543 | -1,341 | -12.32% | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 11,648 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 200 | -100 | -33.33% | Mar 31, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 10,986 | - | - | Mar 28, 2024 |
Caribou Biosciences's largest mutual fund holder by % of total assets is "Kelly Strategic ETF Trust", owning 21.78K shares, compromising 0.80% of its total assets.
Caribou Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 53 | -65.81% |
| 31 Mar, 24 | 155 | 7.64% |
| 31 Dec, 23 | 144 | 10.77% |
| 30 Sep, 23 | 130 | 4.84% |
| 30 Jun, 23 | 124 | -1.59% |
| 31 Mar, 23 | 126 | -5.26% |
| 31 Dec, 22 | 133 | 14.66% |
| 30 Sep, 22 | 116 | -4.13% |
| 30 Jun, 22 | 121 | 16.35% |
| 31 Mar, 22 | 104 | 8.33% |
| 31 Dec, 21 | 96 | 10.34% |
| 30 Sep, 21 | 87 | - |
As of 30 Jun 24, 53 institutions are holding Caribou Biosciences's shares, representing a decrease of -65.81% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 10,198,437 | -84.72% |
| 31 Mar, 24 | 66,737,162 | -3.26% |
| 31 Dec, 23 | 68,986,388 | -2.47% |
| 30 Sep, 23 | 70,733,265 | 61.93% |
| 30 Jun, 23 | 43,682,237 | -2.72% |
| 31 Mar, 23 | 44,903,395 | 3.22% |
| 31 Dec, 22 | 43,502,170 | 0.71% |
| 30 Sep, 22 | 43,194,748 | 15.79% |
| 30 Jun, 22 | 37,305,081 | 9.43% |
| 31 Mar, 22 | 34,089,255 | 9.74% |
| 31 Dec, 21 | 31,062,731 | 3.33% |
| 30 Sep, 21 | 30,061,359 | - |
Caribou Biosciences (CRBU) has 10.20M shares outstanding as of 30 Jun 24, down -84.72% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 11.42% | 0.20% |
| 31 Mar, 24 | 75.47% | 1.11% |
| 31 Dec, 23 | 82.34% | 0.62% |
| 30 Sep, 23 | 115.17% | 2.26% |
| 30 Jun, 23 | 71.39% | 1.33% |
| 31 Mar, 23 | 73.39% | 1.43% |
| 31 Dec, 22 | 71.55% | 1.42% |
| 30 Sep, 22 | 70.94% | 1.88% |
| 30 Jun, 22 | 61.40% | 1.94% |
| 31 Mar, 22 | 56.30% | 2.11% |
| 31 Dec, 21 | 51.62% | 1.20% |
| 30 Sep, 21 | 65.51% | - |
As of 30 Jun 24, Caribou Biosciences is held by 11.42% institutional shareholders, representing a 0.20% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -71.23% |
| 31 Mar, 24 | 73 | -10.98% |
| 31 Dec, 23 | 82 | -1.20% |
| 30 Sep, 23 | 83 | 29.69% |
| 30 Jun, 23 | 64 | 6.67% |
| 31 Mar, 23 | 60 | -6.25% |
| 31 Dec, 22 | 64 | - |
| 30 Sep, 22 | 64 | -3.03% |
| 30 Jun, 22 | 66 | 3.13% |
| 31 Mar, 22 | 64 | 8.47% |
| 31 Dec, 21 | 59 | -32.18% |
| 30 Sep, 21 | 87 | - |
21 institutional shareholders have increased their position in CRBU stock as of 30 Jun 24 compared to 73 in the previous quarter (a -71.23% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 16 | -63.64% |
| 31 Mar, 24 | 44 | 33.33% |
| 31 Dec, 23 | 33 | 57.14% |
| 30 Sep, 23 | 21 | -12.50% |
| 30 Jun, 23 | 24 | -27.27% |
| 31 Mar, 23 | 33 | -13.16% |
| 31 Dec, 22 | 38 | 58.33% |
| 30 Sep, 22 | 24 | -25.00% |
| 30 Jun, 22 | 32 | 77.78% |
| 31 Mar, 22 | 18 | 63.64% |
| 31 Dec, 21 | 11 | - |
| 30 Sep, 21 | - | - |
16 institutional shareholders have reduced their position in CRBU stock as of 30 Jun 24 compared to 44 in the previous quarter (a -63.64% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 53 | -65.81% | 10,198,437 | -84.72% | 11.42% | 0.20% | 21 | -71.23% | 16 | -63.64% |
| 31 Mar, 24 | 155 | 7.64% | 66,737,162 | -3.26% | 75.47% | 1.11% | 73 | -10.98% | 44 | 33.33% |
| 31 Dec, 23 | 144 | 10.77% | 68,986,388 | -2.47% | 82.34% | 0.62% | 82 | -1.20% | 33 | 57.14% |
| 30 Sep, 23 | 130 | 4.84% | 70,733,265 | 61.93% | 115.17% | 2.26% | 83 | 29.69% | 21 | -12.50% |
| 30 Jun, 23 | 124 | -1.59% | 43,682,237 | -2.72% | 71.39% | 1.33% | 64 | 6.67% | 24 | -27.27% |
| 31 Mar, 23 | 126 | -5.26% | 44,903,395 | 3.22% | 73.39% | 1.43% | 60 | -6.25% | 33 | -13.16% |
| 31 Dec, 22 | 133 | 14.66% | 43,502,170 | 0.71% | 71.55% | 1.42% | 64 | - | 38 | 58.33% |
| 30 Sep, 22 | 116 | -4.13% | 43,194,748 | 15.79% | 70.94% | 1.88% | 64 | -3.03% | 24 | -25.00% |
| 30 Jun, 22 | 121 | 16.35% | 37,305,081 | 9.43% | 61.40% | 1.94% | 66 | 3.13% | 32 | 77.78% |
| 31 Mar, 22 | 104 | 8.33% | 34,089,255 | 9.74% | 56.30% | 2.11% | 64 | 8.47% | 18 | 63.64% |
| 31 Dec, 21 | 96 | 10.34% | 31,062,731 | 3.33% | 51.62% | 1.20% | 59 | -32.18% | 11 | - |
| 30 Sep, 21 | 87 | - | 30,061,359 | - | 65.51% | - | 87 | - | - | - |
Caribou Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Caribou Biosciences's stock was made by Kanner Steven on Feb 08 2024, selling 30,577 shares at $2.69 per share (valued at $82.25K).
Caribou Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 19 | 1 | 1900.00% |
| Q2 2023 | 1 | 1 | 100.00% |
| Q1 2023 | 14 | 2 | 700.00% |
| Q4 2022 | 3 | 6 | 50.00% |
| Q3 2022 | 6 | 5 | 120.00% |
| Q2 2022 | 7 | 6 | 116.67% |
| Q1 2022 | 11 | 11 | 100.00% |
| Q4 2021 | 23 | 9 | 255.56% |
| Q3 2021 | 5 | 22 | 22.73% |
| Q1 2018 | - | 1 | - |
| Q3 2017 | - | 1 | - |
| Q2 2016 | 2 | 5 | 40.00% |
19 total buy trades, and 1 total sell trades (buy/sell ratio of 19.00%) were made by Caribou Biosciences's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 1 | - |
| Q4 2022 | - | 1 | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 2 | - | - |
| Q4 2021 | 9 | - | - |
| Q3 2021 | - | - | - |
| Q1 2018 | - | 1 | - |
| Q3 2017 | - | 1 | - |
| Q2 2016 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Caribou Biosciences's stocks.
Caribou Biosciences Peer Ownership
CRBU Ownership FAQ
Who Owns Caribou Biosciences?
Caribou Biosciences is owned by institutional shareholders (11.42%), insiders (10.05%), and public (78.53%). The largest institutional shareholder of Caribou Biosciences is BLACKROCK INC. (7.78% of total shares) and the top mutual fund owner is Kelly Strategic ETF Trust (0.80% of total shares).
Who are the major institutional shareholders of Caribou Biosciences?
Caribou Biosciences's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, PFM HEALTH SCIENCES, LP, and DIMENSIONAL FUND ADVISORS LP. The top five shareholders own together 25.04% of the company's share outstanding.
How many Caribou Biosciences shareholders are there?
As of Jun 2024, there are 53 institutional shareholders of Caribou Biosciences.
What percentage of Caribou Biosciences is owned by BLACKROCK INC?
BLACKROCK INC owns 6.95M shares of Caribou Biosciences, representing 7.78% of the company's total shares outstanding, valued at $11.39M (as of Jun 2024).
What percentage of Caribou Biosciences is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 4.54M shares of Caribou Biosciences (CRBU), compromising 5.09% of the company, valued at $7.45M.
What percentage of Caribou Biosciences is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ is the third largest holder of Caribou Biosciences. The company owns 4.16M of the company's shares outstanding (worth $6.83M).